These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 36457557)

  • 1. Glutamatergic system components as potential biomarkers and therapeutic targets in cancer in non-neural organs.
    García-Gaytán AC; Hernández-Abrego A; Díaz-Muñoz M; Méndez I
    Front Endocrinol (Lausanne); 2022; 13():1029210. PubMed ID: 36457557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutamatergic Signaling in the Central Nervous System: Ionotropic and Metabotropic Receptors in Concert.
    Reiner A; Levitz J
    Neuron; 2018 Jun; 98(6):1080-1098. PubMed ID: 29953871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutamate receptors in pediatric tumors of the central nervous system.
    Brocke KS; Staufner C; Luksch H; Geiger KD; Stepulak A; Marzahn J; Schackert G; Temme A; Ikonomidou C
    Cancer Biol Ther; 2010 Mar; 9(6):455-68. PubMed ID: 20061814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Main path and byways: non-vesicular glutamate release by system xc(-) as an important modifier of glutamatergic neurotransmission.
    Massie A; Boillée S; Hewett S; Knackstedt L; Lewerenz J
    J Neurochem; 2015 Dec; 135(6):1062-79. PubMed ID: 26336934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ionotropic and metabotropic glutamate receptor structure and pharmacology.
    Kew JN; Kemp JA
    Psychopharmacology (Berl); 2005 Apr; 179(1):4-29. PubMed ID: 15731895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulatory effects of Ampicillin/Sulbactam on glial glutamate transporters and metabotropic glutamate receptor 1 as well as reinstatement to cocaine-seeking behavior.
    Hammad AM; Alasmari F; Althobaiti YS; Sari Y
    Behav Brain Res; 2017 Aug; 332():288-298. PubMed ID: 28624317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic potential of metabotropic glutamate receptor modulators.
    Hovelsø N; Sotty F; Montezinho LP; Pinheiro PS; Herrik KF; Mørk A
    Curr Neuropharmacol; 2012 Mar; 10(1):12-48. PubMed ID: 22942876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional regulation of glutamate signaling during cuprizone-induced demyelination in the brain.
    Azami Tameh A; Clarner T; Beyer C; Atlasi MA; Hassanzadeh G; Naderian H
    Ann Anat; 2013 Oct; 195(5):415-23. PubMed ID: 23711509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutamate signaling in benign and malignant disorders: current status, future perspectives, and therapeutic implications.
    Willard SS; Koochekpour S
    Int J Biol Sci; 2013; 9(7):728-42. PubMed ID: 23983606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutamate, T cells and multiple sclerosis.
    Levite M
    J Neural Transm (Vienna); 2017 Jul; 124(7):775-798. PubMed ID: 28236206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The glutamatergic system outside the CNS and in cancer biology.
    Kalariti N; Pissimissis N; Koutsilieris M
    Expert Opin Investig Drugs; 2005 Dec; 14(12):1487-96. PubMed ID: 16307489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutamate transporters and presynaptic metabotropic glutamate receptors protect neocortical Cajal-Retzius cells against over-excitation.
    Dvorzhak A; Unichenko P; Kirischuk S
    Pflugers Arch; 2012 Aug; 464(2):217-25. PubMed ID: 22665047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supraspinal metabotropic glutamate receptors: a target for pain relief and beyond.
    Palazzo E; Marabese I; de Novellis V; Rossi F; Maione S
    Eur J Neurosci; 2014 Feb; 39(3):444-54. PubMed ID: 24494684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Excitatory amino acid receptors].
    Shinozaki H
    Nihon Yakurigaku Zasshi; 1994 Sep; 104(3):177-87. PubMed ID: 7959410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles and regulation of glutamate transporters in the central nervous system.
    O'Shea RD
    Clin Exp Pharmacol Physiol; 2002 Nov; 29(11):1018-23. PubMed ID: 12366395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabotropic glutamate receptors as a strategic target for the treatment of epilepsy.
    Alexander GM; Godwin DW
    Epilepsy Res; 2006 Sep; 71(1):1-22. PubMed ID: 16787741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. System xc⁻ cystine/glutamate antiporter: an update on molecular pharmacology and roles within the CNS.
    Bridges RJ; Natale NR; Patel SA
    Br J Pharmacol; 2012 Jan; 165(1):20-34. PubMed ID: 21564084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystine/glutamate antiporter blockage induces myelin degeneration.
    Soria FN; Zabala A; Pampliega O; Palomino A; Miguelez C; Ugedo L; Sato H; Matute C; Domercq M
    Glia; 2016 Aug; 64(8):1381-95. PubMed ID: 27247047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis.
    Heath PR; Shaw PJ
    Muscle Nerve; 2002 Oct; 26(4):438-58. PubMed ID: 12362409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunochemical localization of the metabotropic glutamate receptors in the rat heart.
    Gill SS; Pulido OM; Mueller RW; McGuire PF
    Brain Res Bull; 1999 Jan; 48(2):143-6. PubMed ID: 10230705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.